Orega Biotech
Get Full AccessDescription
- OREGA Biotech specializes in the discovery and the development of first-in-class monoclonal antibodies for cancer immunotherapy. With a specific focus on tumor microenvironment, OREGAs Target Discovery Program aims at discovering and validating novel clinically-relevant cancer targets.Incepted in 2010, OREGA Biotech is based on the research conducted by its academic cofounders Nathalie Bonnefoy, Armand Bensussan and Jean-François Eliaou. OREGAs business strategy is to bring its R&D programs up to preclinical proof of concept, IND or early clinical stages and then to license them out to larger biotech or pharmaceutical companies. Funded by initiative Octalfa, SHAM Innovation Santé, Rhône-Alpes Création and INSERM-Transfert Initiative, the company is managed by Gilles Alberici, CEO and Jeremy Bastid, COO.
-
Headquarters:15 Chemin Du Saquin , Ecully, , United States
More -
Phone Number:
-
Website: https://www.orega-biotech.com
-
Employees:6
-
Revenue:$1 - 10M
-
Legal Name:Orega Biotech
-
Orega Biotech's Social Media
-
Is this data correct?
-
| NAICS Code: 541611 |
Show More
Frequently Asked Questions regarding Orega Biotech
-
Where are Orega Biotech's Headquarters?
Orega Biotech's Headquarters are in 15 Chemin Du Saquin ,Ecully,,United States
-
What is Orega Biotech's official website?
Orega Biotech's official website is https://www.orega-biotech.com
-
What is Orega Biotech's Revenue?
Orega Biotech's revenue is $1 - 10M
-
What is Orega Biotech's NAICS code?
Orega Biotech's NAICS code is 541611
-
How many employees are working in Orega Biotech
Orega Biotech has 6 employees
-
What is Orega Biotech's Industry?
Orega Biotech is in the industry of Research
-
Who is Orega Biotech's CEO?
Orega Biotech's CEO is Jeremy Bastid
-
Who is Orega Biotech's Project Manager?
Orega Biotech's Project Manager is Claire Tolza

